Peptide topic · 4 records
Anti-aging and longevity peptides
A lab result does not prove a longer or healthier life in people.
Before you compare
Start with four simple questions.
Use them as you open a peptide record or compare results.
- 01
What is the main result this topic can support?
- 02
Did the evidence come from people, animals, or cells?
- 03
Was the exact product and use tested?
- 04
What is still unknown about safety, quality, or personal use?
Exact limit
A laboratory mechanism can be worth studying without proving longer life, healthier aging, or disease prevention in people.
- Peptides reviewed
- 4
- Strongest evidence
- 1
- Claims checked
- 18
Research detailsRead the topic background and related guides
Topic summary
Separate cell, mitochondrial, telomere, and body-marker research from evidence that people live longer or stay healthier.
What these peptides have in common
P21, MOTS-c, and epitalon are graded Insufficient. Their cell or animal findings do not prove a health benefit in people. SS-31 (elamipretide) has one FDA-approved product, Forzinity, for a narrow Barth syndrome use. That approval does not cover other products or uses.
Claims about these molecules often move from brain-cell, mitochondrial, or telomere findings to claims about aging. Early findings and one narrow approval do not prove longer life or healthier aging. Each brief shows what researchers studied and what remains unknown.
Research questions
Questions behind this topic.
- 01
Was the evidence generated in a dish, an animal, or a treated human?
- 02
Is the intervention in the paper identical to the marketed product?
- 03
Was any patient-centered aging outcome measured?
Peptide records
Open each record to see its evidence.
- Approved human outcomesApproved products have evidence from studies in people that measured health results for specific uses. This does not show that every product, person, or use has the same result.EstablishedAn official agency review or strong, repeated studies in people support one clear use. That evidence applies only to the product, people, and use we reviewed. It does not mean the product is safe or effective for everyone.
SS-31
SS-31 is elamipretide. FDA approved Forzinity for one narrow use, not for anti-aging.
6 claims checked · Open evidence brief ↗ - Preclinical or formulation evidenceThe research used cells, animals, or product-form tests. It does not establish benefit or safety in people.InsufficientReliable studies in people are missing, too limited, or do not support the claim. This does not prove that the substance has no effect on the body.
MOTS-c
A peptide first studied in cells and animals. It has no established outcomes from giving a MOTS-c drug product to people or adequate clinical safety record.
3 claims checked · Open evidence brief ↗ - Preclinical or formulation evidenceThe research used cells, animals, or product-form tests. It does not establish benefit or safety in people.InsufficientReliable studies in people are missing, too limited, or do not support the claim. This does not prove that the substance has no effect on the body.
Epitalon
A four-amino-acid peptide promoted for sleep and longevity. Its evidence has identity-transfer problems and no established insomnia or lifespan outcome evidence.
3 claims checked · Open evidence brief ↗ - Preclinical or formulation evidenceThe research used cells, animals, or product-form tests. It does not establish benefit or safety in people.InsufficientReliable studies in people are missing, too limited, or do not support the claim. This does not prove that the substance has no effect on the body.
P21 peptide
P21 peptide is also called P021 or P-21. Its benefits and safety in people are not known.
6 claims checked · Open evidence brief ↗